There were no differences in any of the clinicopathological features according to YAP/TAZ expression status in the CAIX-negative group, except for a tendency for more frequent lymph node metastasis (p = 0.061). The gene discussed is CA9; the disease is metastatic malignant neoplasm in the lymph nodes.